Safety of everolimus in estrogen receptor-positive advanced breast cancer.

被引:0
|
作者
Perez, Alejandra T. [1 ]
机构
[1] Mem Canc Inst, Hollywood, FL USA
关键词
D O I
10.1200/jco.2012.30.27_suppl.103
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
103
引用
收藏
页数:1
相关论文
共 50 条
  • [1] MANAGEMENT OF EVEROLIMUS-RELATED ADVERSE EVENTS IN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR-POSITIVE ADVANCED BREAST CANCER.
    Peterson, Mary
    [J]. ONCOLOGY NURSING FORUM, 2012, 39 (03) : E188 - E188
  • [2] Progesterone receptor signaling in estrogen receptor-positive breast cancer.
    Young, Amy
    Guan, Jane
    Daemen, Anneleen
    Friedman, Lori
    Lin, Kui
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 81 - 81
  • [3] New and emerging treatments for estrogen receptor-positive breast cancer: focus on everolimus
    Paplomata, Elisavet
    O'Regan, Ruth
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 27 - 36
  • [4] Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer.
    Moore, Halle C. F.
    Maiti, Baidehi
    Rybicki, Lisa A.
    Booth, Christine
    Abraham, Jame
    Budd, G. Thomas
    Andresen, Steven Ware
    Downs-Kelly, Erinn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Efficacy of palbociclib after everolimus in hormone receptor-positive, HER2-negative advanced breast cancer.
    Kovac, Anja
    Kuhar, Cvetka Grasic
    Ovcaricek, Tanja
    Matos, Erika
    Mencinger, Marina
    Borstnar, Simona
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
    Barrios, C. H.
    Sampaio, C.
    Vinholes, J.
    Caponero, R.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (07) : 1157 - 1162
  • [7] Complete estrogen blockade in advanced postmenopausal receptor-positive breast cancer
    [J]. Nature Clinical Practice Oncology, 2008, 5 (2): : 67 - 67
  • [8] Everolimus in the treatment of hormone receptor-positive breast cancer
    Chavez-MacGregor, Mariana
    Gonzalez-Angulo, Ana Maria
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1835 - 1843
  • [9] EVEROLIMUS TREATMENT FOR HORMONE RECEPTOR-POSITIVE BREAST CANCER
    不详
    [J]. CANCER DISCOVERY, 2012, 2 (01) : 12 - 12
  • [10] Bicalutamide Plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer
    Lu, Qianyi
    Xia, Wen
    Lee, Kaping
    Zhang, Jingmin
    Yuan, Huimin
    Yuan, Zhongyu
    Shi, Yanxia
    Wang, Shusen
    Xu, Fei
    [J]. ONCOLOGIST, 2020, 25 (01): : 21 - +